Treatment of Meningiomas in India at the finest cancer hospitals is a team process. Specialists from the brain cancer treatment team work together to provide the high-quality, integrated care for which India is known. Generally, a neurologist who has expertise and additional training in neuro-oncology will coordinate the care team. In addition, the neuro-oncologist will counsel the patient about neurological issues and accordingly the treatment of Meningiomas in India is planned.
What is Meningiomas?
Meningiomas are rarely malignant in their behavior. But when malignant, meningiomas grow rapidly and are destructive; they are quite difficult to treat and recur often within less than a year after surgical removal. Meningiomas commonly are found at the surface of the brain, either over the convexity or at the skull base. In rare cases, meningiomas occur in an intraventricular or intraosseous location. The problem of classifying meningioma is that arachnoidal cells may express both mesenchymal and epithelial characteristics. Other mesodermal structures also may give rise to similar tumors (e.g., hemangiopericytomas or sarcomas). The classification of all of these tumors together is controversial. The current trend is to separate unequivocal meningiomas from other less well-defined neoplasms.
Signs and symptoms of Meningiomas
For Meningiomas, the clinical symptoms are usually dependent on the anatomic site involved, but many are found incidentally. Most meningiomas are slow growing and cause signs and symptoms by compression of nearby structures. The three most common symptoms are headaches, mental status changes and paresis, and the most common signs are paresis, normal examinations and memory impairment. For Meningiomas, the most common signs and symptoms are seizures and headache. The lower grade glial tumors have a more indolent course that may persist over years, whereas the most aggressive tumors (e.g., anaplastic oligodendrogliomas, anaplastic astrocytomas, glioblastoma multiforme) may have a rapid onset of neurologic decline. Patients may, however, present with signs and symptoms of increased intracranial pressure, including nausea, vomiting, headache, and confusion.
Friends:
Friends